Cargando…
EZH2 Exacerbates Breast Cancer by Methylating and Activating STAT3 Directly
Breast cancer is one of the most common causes of female death globally. Numerous clinical drugs for breast cancer have been developed, but the unsatisfactory, inevitable side effects and drug resistance are the emerging threatens. Therefore, it is necessary to investigate the comprehensive mechanis...
Autores principales: | Zhao, Yi, Hu, Zhansheng, Li, Jincheng, Hu, Tingyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317538/ https://www.ncbi.nlm.nih.gov/pubmed/34335938 http://dx.doi.org/10.7150/jca.50675 |
Ejemplares similares
-
EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
por: Yoo, Kyung Hyun, et al.
Publicado: (2011) -
EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis
por: Huang, Changsheng, et al.
Publicado: (2022) -
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers
por: Ko, How-Wen, et al.
Publicado: (2016) -
STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer
por: Pan, Yuan-Ming, et al.
Publicado: (2016) -
PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer
por: Chen, Qianzhi, et al.
Publicado: (2023)